Mounjaro Weekly Injection Pen
  1. Home
  2. Mounjaro
  3. Mounjaro Weekly Injection Pen

Mounjaro Weekly Injection Pen

Mounjaro Weekly Injection Pen is a prescription dual GIP and GLP-1 receptor agonist prefilled injection pen used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is designed for once-weekly subcutaneous administration with accurate and reliable dose delivery. The long-acting formulation offers convenient weekly treatment using a ready-to-use injection pen.

BUY NOW

Category

Mounjaro Weekly Injection Pen contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The once-weekly prefilled injection pen provides sustained therapeutic activity with precise subcutaneous administration across multiple dosage strengths. Manufactured under stringent pharmaceutical quality standards, the sterile injection pen is engineered for dependable clinical performance and convenient patient use throughout the prescribed treatment period. Mounjaro Weekly Injection Pen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro Weekly Injection Pen
Active Ingredient Tirzepatide
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro Weekly Injection Pen, Mounjaro Injection Pen, Weekly Tirzepatide Pen, Tirzepatide Prefilled Pen, GIP GLP-1 Injection Pen, Diabetes Injection Pen, Tirzepatide Injectable Pen